Metabolic Health12 min read·Published October 11, 2026

Insulin Resistance Treatment: What Helps, What to Test, and When Medication May Fit

A plain-English guide to food, exercise, weight loss, testing, metformin, GLP-1 options, and when to get clinician help.

Insulin Resistance Treatment: What Helps, What to Test, and When Medication May Fit

Insulin resistance is usually treated first with changes that help muscle, liver, and fat cells respond better to insulin: regular physical activity, weight loss when appropriate, lower-glycemic high-fiber eating, and better sleep. Medication may help when insulin resistance overlaps with prediabetes, type 2 diabetes, PCOS, obesity, fatty liver disease, or severe metabolic disease 1.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

What is insulin resistance, and why does it matter?

Insulin resistance means the body’s cells do not respond to insulin as well as expected. Insulin still matters, but the pancreas may need to release more of it to keep blood sugar in range 1.

Insulin helps move glucose from the blood into muscle and fat cells, and it tells the liver how much glucose to release. When cells become less sensitive to insulin, glucose control can get harder over time, and the body may show signs such as hyperinsulinemia, higher triglycerides, visceral adiposity, fatty liver disease, dyslipidemia, hypertension, prediabetes, or type 2 diabetes 1, 2.

If you want a deeper plain-English explainer, our guide to what insulin resistance is covers causes, symptoms, and testing in more detail.

What are the quick facts about insulin resistance treatment?

Insulin resistance treatment usually starts with the highest-evidence, lowest-risk steps: movement, food quality, sleep, and weight management when appropriate. Medication is not one-size-fits-all; it depends on whether the person has prediabetes, type 2 diabetes, PCOS, fatty liver disease, kidney disease, cardiovascular risk, or medication-related insulin resistance 1.

Insulin resistance often has no symptoms at first

Early insulin resistance can be quiet because the pancreas may make extra insulin to keep glucose in a normal range. That extra insulin is called hyperinsulinemia, and it can hide the problem until blood sugar, A1C, triglycerides, blood pressure, or liver markers start to change 1.

Lifestyle change is the usual first-line treatment

Dietary change and physical activity are core first steps for insulin resistance related to prediabetes and type 2 diabetes risk. Reviews describe lifestyle intervention as a major treatment path because it can improve calorie use, body composition, and insulin sensitivity across tissues 1.

Weight loss may improve insulin sensitivity when excess weight is part of the picture

When excess adiposity is contributing, weight loss may help the liver and muscles respond better to insulin. This does not mean every person with insulin resistance needs weight loss; the right goal depends on body composition, labs, medical history, and clinician assessment 1.

Medication depends on the diagnosis, risks, and lab results

Metformin, thiazolidinediones, incretin-based medicines, insulin strategies, and specialist care may all be used in different settings. The important point is that medication is chosen for the person’s full diagnosis, not for the phrase “insulin resistance” alone 7, 8, 9.

What are the warning signs of insulin resistance?

Warning signs can be subtle. Many people notice nothing at first, while others first learn about insulin resistance through rising A1C, fasting glucose, triglycerides, waist size, blood pressure, liver enzymes, PCOS symptoms, or dark velvety skin changes 1.

Why many people do not notice symptoms early

The body can compensate for a while by making more insulin. That is why a person can have insulin resistance before they have high blood sugar or classic diabetes symptoms 1.

Possible clues: rising A1C, fasting glucose, waist size, triglycerides, fatty liver, PCOS, or skin changes

Insulin resistance often travels with metabolic syndrome features: abdominal fat, higher triglycerides, lower HDL cholesterol, higher blood pressure, and higher glucose. It can also overlap with polycystic ovary syndrome, fatty liver disease, and obesity-related metabolic risk 1, 2.

When to ask about testing

Ask a clinician about testing if you have a family history of type 2 diabetes, prior gestational diabetes, PCOS, fatty liver disease, high triglycerides, high blood pressure, unexplained weight gain, or rising glucose results. If you already have abnormal labs, our guide on how to know if you have insulin resistance can help you prepare questions for your visit.

How is insulin resistance tested or evaluated?

Testing insulin resistance usually starts with practical glucose and cardiometabolic markers, not a single perfect test. A clinician may use A1C, fasting plasma glucose, oral glucose tolerance testing, lipids, liver enzymes, blood pressure, kidney labs, and medical history to understand the bigger picture 1.

A1C, fasting glucose, and oral glucose tolerance testing

A1C estimates average blood sugar over about 2 to 3 months. Fasting plasma glucose checks glucose after an overnight fast. An oral glucose tolerance test measures how the body handles a glucose drink over time and can uncover problems that fasting labs may miss 1.

Fasting insulin and HOMA-IR: why they are not always routine

Fasting insulin and HOMA-IR can estimate insulin resistance in some clinical or research settings. But they are not always routine because insulin tests vary, results can be hard to interpret, and treatment decisions often depend more on glucose status, cardiometabolic risk, and related conditions 1.

Related labs: lipids, liver enzymes, blood pressure, and kidney health

A full evaluation often looks beyond glucose. Triglycerides, HDL cholesterol, liver enzymes, kidney function, urine albumin, blood pressure, medications, sleep, and alcohol use can all change the treatment plan 1, 7.

When severe insulin resistance needs specialist evaluation

Severe insulin resistance is often discussed when someone needs more than 2 units/kg/day or more than 200 units/day of insulin. These cases may require an endocrinologist, medication review, and sometimes concentrated insulin such as U-500 insulin under specialist care 7.

What is the best first treatment for insulin resistance?

The best first treatment is usually a plan that improves insulin sensitivity without overcomplicating life: more movement, stronger muscles, higher-fiber meals, enough protein, sleep support, and weight loss when excess adiposity is contributing. These steps are not quick fixes, but they are the foundation 1.

Physical activity and muscle glucose uptake

Muscle is a major glucose-using tissue. Regular physical activity helps muscles use glucose and can improve insulin sensitivity across the body, even before major weight loss occurs 1.

Weight loss when excess adiposity is contributing

When visceral adiposity is part of the problem, losing weight can reduce the metabolic strain on liver, muscle, and fat tissue. For more detail, see our guide to losing weight with insulin resistance.

Lower-glycemic, higher-fiber eating patterns

Lower-glycemic carbohydrates, minimally processed foods, and dietary fiber can reduce glucose spikes and support fullness. Reviews of insulin resistance treatment describe calorie reduction when weight loss is appropriate and reducing high-glycemic-index carbohydrates as common dietary strategies 1.

Sleep, stress, alcohol, and medication review

Sleep loss, heavy alcohol use, chronic stress, and some medications can worsen glucose control. Glucocorticoids, protease inhibitors, atypical antipsychotics, and calcineurin inhibitors are among medications linked with severe insulin resistance, but they should not be stopped without clinician guidance 7.

What foods can help improve insulin sensitivity?

Foods for insulin sensitivity are usually not exotic. The basics are high-fiber carbohydrates, minimally processed foods, adequate protein, unsaturated fats, and fewer sugary drinks or refined starches that create large glucose spikes 1.

High-fiber carbohydrates and minimally processed foods

Beans, lentils, oats, barley, vegetables, berries, nuts, seeds, and intact whole grains tend to digest more slowly than refined grains and sugary foods. This can make post-meal glucose rises smaller and help with fullness 1.

Protein and satiety: what the evidence suggests

A controlled inpatient crossover trial by Tettamanzi and colleagues compared a high-protein diet with a Mediterranean diet in the studied population and found greater improvement in insulin resistance and glycemic variability with the high-protein diet. This is one trial, not proof that one diet is best for everyone 3.

Mediterranean-style eating and lower-glycemic swaps

A Mediterranean-style pattern can still be useful because it emphasizes vegetables, legumes, fish, olive oil, nuts, and minimally processed foods. Lower-glycemic swaps often matter more than a perfect diet label: oats instead of sweet cereal, beans instead of white rice alone, water instead of soda, and fruit instead of juice.

Foods and drinks that often worsen glucose spikes

Sugary drinks, candy, pastries, white bread, large portions of refined starch, and alcohol-heavy patterns can worsen glucose swings for many people. If you have prediabetes or diabetes, our guides on foods to avoid with diabetes and a healthy diet for insulin resistance go deeper.

Which exercises help insulin resistance most?

Exercise for insulin resistance works best when it combines aerobic activity, resistance training, and less sitting time. The goal is not punishment; it is giving muscle regular reasons to use glucose 1.

Aerobic activity

Brisk walking, cycling, swimming, dancing, and other aerobic activities help the body use energy and can improve insulin sensitivity. Starting with short, repeatable sessions is often better than aiming for a perfect plan that is hard to keep.

Resistance training and muscle mass

Resistance training builds or preserves muscle, and muscle is one of the main tissues that clears glucose from the blood. Bands, machines, dumbbells, body-weight moves, or supervised training can all count when done safely 1.

Short walks after meals

A short walk after meals can help muscles use some of the glucose entering the bloodstream, and physical activity is a core lifestyle strategy for improving insulin sensitivity 1. It is a simple habit that many people can add without changing their whole exercise schedule.

How to start safely if you are inactive or have medical conditions

If you have chest pain, shortness of breath, neuropathy, eye disease, kidney disease, severe obesity, or you take insulin or sulfonylureas, ask a clinician how to start safely. Activity is helpful, but the safest plan should match your health status.

Can insulin resistance be cured quickly?

A fast cure is the wrong goal. Insulin sensitivity can improve quickly with movement and food changes, but A1C, liver fat, body composition, and medication needs usually change over weeks to months 1.

Why “fast cure” is the wrong goal

Insulin resistance is usually driven by several forces at once: genetics, body composition, sleep, stress, medication effects, hormones, liver fat, and activity level. Because the causes differ, the timeline differs too.

What can improve within days to weeks

Post-meal glucose patterns may improve within days to weeks when someone adds walking, reduces sugary drinks, improves sleep, or changes carbohydrate quality; reviews describe physical activity, dietary change, and related lifestyle measures as core approaches for insulin resistance 1. These early changes are encouraging, but they do not always mean the underlying risk is gone.

What usually takes months: body composition, A1C, liver fat, and medication needs

A1C reflects roughly 2 to 3 months of glucose exposure, so it does not move overnight. Body composition, fatty liver disease, blood pressure, and medication needs also require follow-up, not guesswork.

What medications are used when lifestyle changes are not enough?

Medication for insulin resistance depends on the clinical diagnosis. Metformin may fit prediabetes, type 2 diabetes, or PCOS-related insulin resistance in some people; other diabetes or weight-loss medicines may fit when specific goals and risks are present 1, 7.

Metformin: where it fits for prediabetes, type 2 diabetes, and PCOS-related insulin resistance

Metformin lowers liver glucose output and can improve insulin sensitivity in common metabolic settings. It is FDA-approved for type 2 diabetes, not for insulin resistance as a stand-alone label; clinicians may consider it in some related settings, such as prediabetes risk or PCOS-related insulin resistance, depending on the person’s risks and goals 1. Our full guide to metformin for insulin resistance explains where it may fit.

Thiazolidinediones and other diabetes medications

Thiazolidinediones improve insulin sensitivity through PPAR-gamma pathways, but they can cause weight gain, fluid retention, and other risks, so they are not right for everyone. Other diabetes medicines may be chosen based on A1C, kidney function, cardiovascular risk, weight goals, and side effect profile 1.

GLP-1 and GIP/GLP-1 medicines when weight loss is a treatment goal

Wegovy and Ozempic contain semaglutide, a GLP-1 receptor agonist; Zepbound and Mounjaro contain tirzepatide, a GIP/GLP-1 receptor agonist. Under FDA-approved brand labels, these active ingredients are used in different ways for chronic weight management or glucose control, and they can cause side effects such as nausea, vomiting, diarrhea, constipation, abdominal pain, and rare but serious risks listed in prescribing information 8, 9.

Severe insulin resistance and concentrated insulin under specialist care

People who need very high insulin doses may need specialist management. Reviews describe U-500 insulin and other strategies for severe insulin resistance, but these approaches require careful prescribing because hypoglycemia, weight gain, dosing errors, and regimen complexity are real concerns 7.

How do weight-loss treatments fit into insulin resistance care?

Weight-loss treatment may fit when insulin resistance overlaps with excess weight or weight-related metabolic risk. It is not a stand-alone “insulin resistance cure,” but in the right patient, weight management can be part of improving insulin sensitivity and cardiometabolic risk 1.

Why weight loss may improve insulin sensitivity in some patients

Visceral adiposity and fatty liver can interfere with insulin signaling. When excess weight is part of the pattern, weight loss may reduce that metabolic pressure and improve glucose, triglycerides, blood pressure, or liver markers over time 1.

Semaglutide and tirzepatide: what they are and what they are not

Semaglutide is a GLP-1 receptor agonist, and tirzepatide is a GIP/GLP-1 receptor agonist. These are incretin-based medicines; they are not insulin, and they are not a diagnosis or cure for insulin resistance. Side effects and contraindications matter, including gastrointestinal symptoms and warnings in the FDA labels 8, 9.

Compounded medications: what patients should understand

Compounded semaglutide via a 503A pharmacy and compounded tirzepatide via a 503A pharmacy are prescription medications prepared for an individual patient when prescribed by a clinician. They are not FDA-approved, and outcomes data are not established for compounded formulations; FDA explains that compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness, or quality before marketing 11. The key safety line is licensed care: a licensed provider evaluation and a state-licensed 503A pharmacy, not no-prescription “research chemical” sellers.

3-min quiz

Considering weight-loss treatment as part of metabolic care?

Chia offers clinician-reviewed access to compounded semaglutide injection and compounded tirzepatide tablets or injection for eligible patients seeking weight-loss treatment. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.

Insulin resistance treatment at Chia: when a GLP-1 path may fit

At Chia, our role is narrow and specific: we offer clinician-reviewed weight-loss care for eligible patients whose goals may overlap with insulin resistance, excess weight, or weight-related metabolic risk. We do not claim to diagnose, cure, or directly treat insulin resistance as a standalone condition.

Chia offers clinician-reviewed care for eligible patients seeking weight-loss treatment

Treatment starts online with a short health questionnaire. A licensed US provider reviews your history and prescribes only when clinically appropriate; a prescription is never guaranteed.

Semaglutide at Chia: compounded semaglutide injection from a state-licensed 503A pharmacy

Chia offers compounded semaglutide injection, with plans currently starting at $249/mo. Dosing is provider-guided and adjusted over time, including microdosing plans where clinically appropriate. Compounded medications are not FDA-approved.

Tirzepatide at Chia: compounded tirzepatide tablets or injection, with microdosing plans available

Chia offers compounded tirzepatide tablets or injection. Plans currently start at $249/mo for tablets and $299/mo for injection, with microdosing plans available when clinically appropriate. Compounded medications are not FDA-approved.

Chia optionForms Chia offersCurrent starting priceHow it may fit
SemaglutideInjectionFrom $249/moFor eligible patients seeking provider-guided weight-loss treatment; microdosing plans available
TirzepatideTablets or injectionTablets from $249/mo; injection from $299/moFor eligible patients seeking provider-guided weight-loss treatment; microdosing plans available

What the online evaluation includes and why a prescription is not guaranteed

Our providers review health history, medications, weight goals, risk factors, and safety issues. If treatment is prescribed, medications are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Patients can message their care team through the portal between visits.

How DoctorMCP can support agent-assisted access to Chia

When someone uses an AI agent to help navigate prescription delivery, Chia is reachable through DoctorMCP at mcp.chia.health. The same clinical rule applies: access starts with an evaluation by a licensed provider, and prescribing is not guaranteed.

What supplements help insulin resistance?

Supplements for insulin resistance have mixed, condition-specific evidence. Some small randomized trials have studied resveratrol, hesperetin, marine oil from Calanus finmarchicus, and myo-inositol, but supplements should not replace testing, nutrition, activity, or needed medication 4, 5, 6, 10.

Why supplement evidence is mixed and condition-specific

A supplement trial in people with type 2 diabetes, chronic periodontitis, obesity, prediabetes, or PCOS may not apply to someone without those conditions. Dose, formulation, baseline diet, medication use, and study length also matter.

Resveratrol, hesperetin, marine oil, and myo-inositol: what small trials suggest

A randomized trial studied resveratrol in people with type 2 diabetes and chronic periodontitis 4. Another trial studied a trans-resveratrol and hesperetin combination in overweight and obese adults 5. Marine oil from Calanus finmarchicus was studied in obese prediabetic individuals 6, and myo-inositol was studied with periodontal therapy in women with PCOS and chronic periodontitis 10. These findings are interesting, but they do not make supplements standard first-line treatment.

Safety, interactions, and why supplements should not replace evaluation

Supplements can interact with diabetes medicines, blood thinners, blood pressure medicines, fertility treatments, and surgery plans. Ask a clinician before starting them, especially if you are pregnant, trying to conceive, taking medication, or managing kidney, liver, or heart disease.

How should you choose a treatment plan?

Choosing a plan starts with the reason insulin resistance is showing up. Prediabetes, type 2 diabetes, PCOS, fatty liver disease, weight management, and severe insulin resistance can all need different next steps 1, 7.

Your situationOften sensible next stepWhy it may fitTrade-offs or cautions
No diabetes diagnosis, but risk factors are presentAsk about A1C, fasting glucose, lipids, blood pressure, liver enzymes, and lifestyle planFinds early risk before symptoms appearNormal glucose does not always rule out insulin resistance
PrediabetesLifestyle intervention; consider medication discussion if risk is highCan lower risk of progression and improve metabolic markersRequires follow-up labs and a realistic plan
Type 2 diabetesDiabetes care plan, often including medicationTargets glucose and long-term complication riskMedication choice depends on A1C, kidneys, heart risk, weight goals, and side effects
PCOS with insulin resistance featuresClinician evaluation; nutrition, activity, weight goals if relevant, and possible metformin discussionPCOS can overlap with hyperinsulinemia and metabolic riskCycle, fertility, acne, hair growth, and metabolic goals may differ
Excess weight with metabolic riskLifestyle plan plus weight-loss treatment discussion when appropriateWeight loss may improve insulin sensitivity for some peopleGLP-1 and GIP/GLP-1 medicines can cause side effects and are not right for everyone
Very high insulin needsEndocrinology evaluationSevere insulin resistance may need concentrated insulin or complex medication changesHigher risk of hypoglycemia, dosing errors, and weight gain

How goals differ for prediabetes, type 2 diabetes, PCOS, fatty liver, and weight management

Prediabetes care often focuses on preventing progression. Type 2 diabetes care focuses on glucose targets and complication prevention. PCOS care may include cycle, fertility, androgen, and metabolic goals. Fatty liver care often centers on weight, alcohol, triglycerides, and liver monitoring. Weight management focuses on sustainable body composition change and safety.

Questions to ask a clinician

  • Which labs suggest insulin resistance or metabolic risk in my case?
  • Do I meet criteria for prediabetes, type 2 diabetes, PCOS, fatty liver disease, or metabolic syndrome?
  • Would weight loss improve my risk profile, or is a different goal more important?
  • Could any of my medications be worsening glucose or insulin resistance?
  • Is metformin, a GLP-1 or GIP/GLP-1 medicine, or another option appropriate for my diagnosis?
  • How often should I recheck A1C, fasting glucose, lipids, liver enzymes, kidney function, and blood pressure?

When should you get medical help now?

Get help now if you have symptoms of very high blood sugar, dehydration, chest pain, severe shortness of breath, confusion, fainting, or severe abdominal pain. Insulin resistance itself is usually not an emergency, but diabetes complications and heart symptoms can be 12.

  • Seek urgent care for confusion, vomiting, severe weakness, trouble breathing, or signs of dehydration with high glucose 12.
  • Call emergency services for chest pain, stroke symptoms, fainting, or severe shortness of breath 12.
  • Book a clinician visit if you have rising A1C, fasting glucose, triglycerides, blood pressure, liver enzymes, or symptoms of PCOS.
  • Do not stop prescribed steroids, antipsychotics, transplant medicines, insulin, or diabetes medicines without medical guidance.

3-min quiz

Start with a clinician-reviewed plan

If weight management is part of your metabolic health plan, Chia can review whether semaglutide or tirzepatide treatment may be appropriate. The visit is online, prescribing is not guaranteed, and compounded medications are not FDA-approved.


References

  1. 1.Kwon H, Pessin JE. Recent Advances in the Treatment of Insulin Resistance. International Journal of Molecular Sciences. 2022.
  2. 2.James DE, Stöckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nature Reviews Molecular Cell Biology. 2021.
  3. 3.Tettamanzi F, Bagnardi V, Louca P, et al. A High Protein Diet Is More Effective in Improving Insulin Resistance and Glycemic Variability Compared to a Mediterranean Diet-A Cross-Over Controlled Inpatient Dietary Study. Nutrients. 2021.
  4. 4.Zare Javid A, Hormoznejad R, Yousefimanesh HA, et al. The Impact of Resveratrol Supplementation on Blood Glucose, Insulin, Insulin Resistance, Triglyceride, and Periodontal Markers in Type 2 Diabetic Patients with Chronic Periodontitis. Phytotherapy Research. 2017.
  5. 5.Rabbani N, Xue M, Weickert MO, et al. Reversal of Insulin Resistance in Overweight and Obese Subjects by trans-Resveratrol and Hesperetin Combination-Link to Dysglycemia, Blood Pressure, Dyslipidemia, and Low-Grade Inflammation. Nutrients. 2021.
  6. 6.Burhop M, Schuchardt JP, Nebl J, et al. Marine Oil from C. finmarchicus Enhances Glucose Homeostasis and Liver Insulin Resistance in Obese Prediabetic Individuals. Nutrients. 2022.
  7. 7.Church TJ, Haines ST. Treatment Approach to Patients With Severe Insulin Resistance. Clinical Diabetes. 2016.
  8. 8.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
  9. 9.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
  10. 10.Deepti, Tewari S, Narula SC, et al. Effect of Non-Surgical Periodontal Therapy Along With Myo-Inositol on High-Sensitivity C-Reactive Protein and Insulin Resistance in Women With Polycystic Ovary Syndrome and Chronic Periodontitis: A Randomized Controlled Trial. Journal of Periodontology. 2017.
  11. 11.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA. 2024.
  12. 12.Mayo Clinic. Hyperglycemia in diabetes: Symptoms and causes. Mayo Clinic. 2024.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides